Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Milo

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2023
The global biomass of wild mammalsLior Greenspoon, Eyal Krieger, Ron Sender, et al.
The Journal of Biological Chemistry|April 26, 2015
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like DiseaseNathali Kaushansky, Miriam Eisenstein, Sigalit Boura-Halfon, et al.
Journal of Neurology|September 10, 2010
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in IsraelZeev Meiner, Esther Kahana, Fanny Baitcher, et al.
Plos One|April 22, 2009
Protein dynamics in individual human cells: experiment and theoryAriel Aharon Cohen, Tomer Kalisky, Avi Mayo, et al.
The New England Journal of Medicine|September 15, 2021
Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Multiple Sclerosis and Related Disorders|February 16, 2021
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionalsAlexey Boyko, Christina Therapontos, Dana Horakova, et al.
Nature Food|October 3, 2024
The Dublin Declaration fails to recognize the need to reduce industrial animal agricultureChris Bryant, Harry Aiking, Roberta Alessandrini, et al.
Journal of Neurology|July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ ViewpointPanayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
Plos Biology|September 8, 2025
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosisLaura Bellassen, Keren David, Bar Lampert, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|October 27, 2021
Waning Immunity after the BNT162b2 Vaccine in IsraelYair Goldberg, Micha Mandel, Yinon M Bar-On, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2023
The global biomass of wild mammalsLior Greenspoon, Eyal Krieger, Ron Sender, et al.
The Journal of Biological Chemistry|April 26, 2015
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like DiseaseNathali Kaushansky, Miriam Eisenstein, Sigalit Boura-Halfon, et al.
Journal of Neurology|September 10, 2010
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in IsraelZeev Meiner, Esther Kahana, Fanny Baitcher, et al.
Plos One|April 22, 2009
Protein dynamics in individual human cells: experiment and theoryAriel Aharon Cohen, Tomer Kalisky, Avi Mayo, et al.
The New England Journal of Medicine|September 15, 2021
Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Multiple Sclerosis and Related Disorders|February 16, 2021
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionalsAlexey Boyko, Christina Therapontos, Dana Horakova, et al.
Nature Food|October 3, 2024
The Dublin Declaration fails to recognize the need to reduce industrial animal agricultureChris Bryant, Harry Aiking, Roberta Alessandrini, et al.
Journal of Neurology|July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ ViewpointPanayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
Plos Biology|September 8, 2025
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosisLaura Bellassen, Keren David, Bar Lampert, et al.
Pageof 18